Advanced Treatments to Treat Obesity and High Blood Sugar The GLP-1 market comprises glucagon-like peptide-1 (GLP-1) receptor agonist drugs, either in the form of orally available drugs, used mainly for the treatment of type-2 diabetes, obesity, and conditions such as heart ailments and chronic kidney ailments
When prescribed for psychiatric indications like alcohol use disorder or binge eating disorder, prior authorization may be required with documentation of off-label rationale
Computational fluid simulation of fibrinogen around dental implant surfaces
Ensenauer R, Fingerhut R, Schriever SC, Fink B, Becker M, Sellerer NC, et al
Gut dysbiosis associated with hepatitis C virus infection